Remove topics affordable-care-act
article thumbnail

Overview of the S. 3 landscape on patenting biotechnology inventions in India

SpicyIP

Section 2(ja) of the Patents Act, 1970 defines an invention as a new product or process involving an inventive step and capable of industrial application and Section 3 specifies various bars to patent protection. 3(e), in La Renon Health Care Pvt. Kibow Biotech Inc., The Court also repelled the challenge to the invention based on S.

article thumbnail

HuffPost Contributor Isn’t an “Agent,” So Their Content Qualifies for Section 230–KGS v. Huffington Post

Technology & Marketing Law Blog

If you care to dive deeper, these appear to be the stories: part 1 and part 2. The plaintiff alleges that “HuffPost, acting through its agent Riben, assisted in ‘creating, developing, and writing’ the articles.” This scenario implicates the quarter-century-old classic 230 case on the topic, Blumenthal v.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SpicyIP Weekly Review (November 6- November 12)

SpicyIP

Other Posts Ayur United Care LLP v. In this month’s edition, he looks into topics including copyright and education, transparency and clinical trial data, Google ad-word cases, and more! 3 Landscape on Patenting Biotechnology Inventions in India How does Section 3 of the Indian Patent Act interact with biotech inventions?

article thumbnail

Previewing the “Lessons from the First Internet Ages” Symposium

Technology & Marketing Law Blog

we need “sustainable business models to maintain and expand the reach of the internet” affordability has been a barrier to Internet adoption. So, I think it being a proper noun is important… if you care about the Internet, capitalize it.” inventors keep finding new applications of the infrastructure.

article thumbnail

2021 Post-Grant Report

Fish & Richardson Trademark & Copyright Thoughts

10 YEARS AFTER THE AMERICA INVENTS ACT (AIA), THE PATENT TRIAL AND APPEAL BOARD (PTAB) ENDURES. 16 should have been afforded based on the petitioner initiating the wire transfer prior to 3:00pm on Dec. Denials of institution – particularly the extent to which they are reviewable – have long been a contentious topic for the PTAB.

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

Litigation under the Biologics Price Competition and Innovation Act (BPCIA) in the district courts also decreased. In the guidance documents, FDA provides “answers to common questions from prospective applicants and other interested parties regarding the Biologics Price Competition and Innovation Act of 2009 (BPCI Act).”

article thumbnail

Catching Up on the 11th Circuit Appeal in NetChoice v. Moody Over Florida’s Social Media Censorship Law

Technology & Marketing Law Blog

” “the Act simply does not impose anything like actual common carriers’ obligations. Those points get some engagement throughout the briefs, but each of them merited a standalone brief rather than the overlapping pileup on other topics. “Florida officials assert that S.B. 7072 benefits its residents.